Showing results (191-200 of 396) with videos related to
Sort By:
Pageof 40
Vascular Medicine (London, England)|July 25, 2019
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trialCharles W Hopley, Sarah Kavanagh, Manesh R Patel, et al.Journal of the American College of Cardiology|February 15, 2020
Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery DiseaseAxel Haine, Sarah Kavanagh, Jeffrey S Berger, et al.Vascular Medicine (London, England)|April 7, 2023
Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) studyE Hope Weissler, Amanda Stebbins, Lisa Wruck, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 24, 2017
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID TrialLars Norgren, Manesh R Patel, William R Hiatt, et al.American Heart Journal|March 21, 2016
Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trialLouis P Kohl, Jeffrey D Leimberger, Karen Chiswell, et al.Clinical Trials (London, England)|February 5, 2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trialAjar Kochar, Mary B Summers, Catherine P Benziger, et al.JAMA Network Open|January 16, 2019
Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID TrialJ Antonio Gutierrez, Hillary Mulder, W Schuyler Jones, et al.American Heart Journal|October 30, 2020
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysisAnubodh S Varshney, David E Wang, Ankeet S Bhatt, et al.Circulation|August 28, 2022
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial InfarctionSunil V Rao, Bodo Kirsch, Deepak L Bhatt, et al.JAMA Cardiology|November 5, 2022
Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic DissectionE Hope Weissler, Oyomoare L Osazuwa-Peters, Melissa A Greiner, et al.Pageof 40